PharmaClik Login 
Dimitris Polygenis - McKesson Canada
Dimitris Polygenis
President, McKesson Canada Specialty Health
Dimitris serves as the President of McKesson Canada Specialty Health. In this capacity, he is dedicated to partnering with providers, payers, and biopharma partners to improve health outcomes and making complex care accessible through integrated, data-driven, and patient-focused solutions.
Dimitris joined McKesson Canada in 2005 following the acquisition of Phase 4 Health, a specialty and manufacturer-facing services company he helped build and grow. This acquisition resulted in the creation of McKesson Canada Specialty Health, which offers a comprehensive range of services to manufacturers. Under his leadership, the group has expanded to become Canada’s largest specialty services provider and McKesson Canada’s fastest-growing business unit. Throughout his tenure at McKesson Canada, Dimitris has led every operational business unit within the Canadian portfolio. A trained pharmacist, Dimitris is recognized as a strategic business leader committed to customer success, operational excellence, and building high-performing teams.
Prior to joining McKesson Canada, Dimitris served as a healthcare consultant to numerous industry stakeholders, including a role with the Ontario Round Table on Appropriate Prescribing (ORTAP) at the Institute for Clinical Evaluative Sciences in Ontario (ICES). He has held multiple teaching and board appointments, including positions at the University of Toronto and University of British Columbia Pharmacy Programs, Neighbourhood Pharmacy Association of Canada (NPAC), Canadian Association for Pharmacy Distribution Management (CAPDM), and the Country Day School.
Dimitris Polygenis
President, McKesson Canada Specialty Health
Dimitris serves as the President of McKesson Canada Specialty Health. In this capacity, he is dedicated to partnering with providers, payers, and biopharma partners to improve health outcomes and making complex care accessible through integrated, data-driven, and patient-focused solutions.
Dimitris joined McKesson Canada in 2005 following the acquisition of Phase 4 Health, a specialty and manufacturer-facing services company he helped build and grow. This acquisition resulted in the creation of McKesson Canada Specialty Health, which offers a comprehensive range of services to manufacturers. Under his leadership, the group has expanded to become Canada’s largest specialty services provider and McKesson Canada’s fastest-growing business unit. Throughout his tenure at McKesson Canada, Dimitris has led every operational business unit within the Canadian portfolio. A trained pharmacist, Dimitris is recognized as a strategic business leader committed to customer success, operational excellence, and building high-performing teams.
Prior to joining McKesson Canada, Dimitris served as a healthcare consultant to numerous industry stakeholders, including a role with the Ontario Round Table on Appropriate Prescribing (ORTAP) at the Institute for Clinical Evaluative Sciences in Ontario (ICES). He has held multiple teaching and board appointments, including positions at the University of Toronto and University of British Columbia Pharmacy Programs, Neighbourhood Pharmacy Association of Canada (NPAC), Canadian Association for Pharmacy Distribution Management (CAPDM), and the Country Day School.
